Troponin Market Synopsis:
Troponin Market Size Was Valued at USD 1.39 Billion in 2023, and is Projected to Reach USD 4.04 Billion by 2032, Growing at a CAGR of 12.6% From 2024-2032.
The troponin market is the testing and measurement procedures employed to measure the presence of troponin proteins in the blood and include heart conditions, including myocardial infarction. Troponin realase is a regulatory protein complex extracted from cardiac muscle; an elevated level of Tropinin in blood seams to reflect myocardial damage. Consequently, the TS assay has evolved into the gold standard in emergency and cardiology department for the efficient and accurate evaluation of patients suspected to have ACS or other cardiac events.
The growth of the troponin market is therefore fuelled by rising incidence of cardiovascular diseases, which include heart attack and coronary artery disease among other diseases throughout the world. Further, improvement in technologies for measurement of Troponin T, in particular high sensitivity Troponin assay, have enhanced the specificity and sensitivity of cardiac diagnosis. Early detection of diseases and the increasing use of point-of-care diagnostics and embedding of troponin tests in diagnostics and clinical pathways, are also shaping the growth of this market. H
ospitals, diagnostic Labs and emergency care centers are the major end user in the troponin test. The market has hurdles mainly high cost of some of the improved troponin tests and need to standardize them in order to produce accurate results.ch are leading causes of mortality worldwide. Additionally, advancements in troponin testing technologies, such as high-sensitivity troponin assays, have improved the accuracy and reliability of cardiac diagnostics. The growing emphasis on early diagnosis, along with the adoption of point-of-care testing and the integration of troponin tests into clinical workflows, is further contributing to the market's expansion. Hospitals, diagnostic labs, and emergency care centers are among the primary end-users of troponin tests.
Troponin Market Trend Analysis:
Rise of High-Sensitivity Troponin Assays
-
There are new high- sensitive troponin assays on the market which offer the capability of measurement of very low concentration of troponin in blood, facilitating improved, early diagnosis of cardiac events. These advanced assays help clinicians diagnose heart attack much earlier than traditional biomarkers and therefore improve patient prognosis due to enhanced intervention. Since more healthcare providers will incorporate these assays, the high-sensitivity cardiac troponin testing is expected to contribute to the market growth in emergency and critical care sections.
Growing Adoption of Point-of-Care Troponin Testing
-
One of the emerging trends is point of care which is easy to perform in emergency departments, out on the ambulance, and outpatient departments because it gives quick results than other methods. The nature of POC testing satisfies the need for quick categorization in ambulatory care and can be advantageous in areas with scarce availability of full-scale laboratory services. It is expected that an increase in the creation of portable and simple to use POC troponin testing devices will expand the application of the troponin and contribute in the growth of the troponin market.
Troponin Market Segment Analysis:
Troponin Market is Segmented on the basis of By Product Type, Application, End User, and Region.
By Product Type, Troponin T segment is expected to dominate the market during the forecast period
-
Depending on the specific product type, the troponin market is divided into Troponin I, Troponin T, Troponin Complex and others which perform a different function in the diagnosis of heart ailments. Considering the specificity of the cardiac marker, Troponin I and Troponin T are two most widely used markers to determine the heart muscle damages particularly in case of myocardial infarction.
- Though Troponin I tend to have higher sensitivity compared to other two, the evaluation of cardiac damage over a long term is possible using Troponin T thus it is useful for full cardiac profiling. Troponin Complex of both I and T is also getting appreciation for the multipurpose diagnostic capabilities. Product differentiation makes it possible for healthcare service providers to select individual troponin tests depending on the need required helping the growth and diversification of the troponin market.
By End User, Hospitals segment expected to held the largest share
-
Hospitals constitute a large part of the total due to the fact that troponin tests done through emergency departments for acute coronary syndromes diagnostics in patients with suspected acute myocardial infarction. An important contribution is also made by diagnostic laboratories they provide specific workup by using highly sensitive troponin assays, especially in the ambulatory and referral settings. Another trend which has seen significant growth characteristics is home care since development of point of care (POC) testing offers caregivers full Metal testing profile of their patients even while in home supervision. Other end-users include ambulatory surgical centers and clinics, which also benefit from the troponin tests in ensuring they provide early reliable diagnosis in order to enhance the performance of patient treatment.
Troponin Market Regional Insights:
North America is Expected to Dominate the Market Over the Forecast period
-
North America is expected to account for the largest equipment and reagents of troponin during the forecast period owing to increased rate of cardiovascular diseases, well-established healthcare facilities, and demand for high-sensitivity troponin assays in the region. The United States stands out, and in addition to spending a considerable amount of money on healthcare, operating a vast network of hospitals, and seeing a trend towards decentralizing diagnostics to the point-of-care for speedier identification of cardiac conditions, it is formulating guidelines. Besides, it is anticipated that North America will continue to dominate the troponin market mainly due to the favourable regulatory policies as well as continuous investments in the technologies related to cardiac care.
Active Key Players in the Troponin Market
- Abbott Laboratories (USA)
- Beckman Coulter (USA)
- bioMérieux SA (France)
- Mitsubishi Chemical Europe (Germany)
- Radiometer Medical ApS (Denmark)
- Response Biomedical (Canada)
- Roche Diagnostics (Switzerland)
- Siemens Healthcare GmbH (Germany)
- Thermo Fisher Scientific (USA)
- Vitro (Spain)
- Other Active players.
|
Troponin Market |
|||
|
Base Year: |
2023 |
Forecast Period: |
2024-2032 |
|
Historical Data: |
2017 to 2023 |
Market Size in 2023: |
USD 1.39 Billion |
|
Forecast Period 2024-32 CAGR: |
12.6% |
Market Size in 2032: |
USD 4.04 Billion |
|
Segments Covered: |
By Product Type |
|
|
|
By Application |
|
||
|
By End User |
|
||
|
By Region |
|
||
|
Key Market Drivers: |
|
||
|
Key Market Restraints: |
|
||
|
Key Opportunities: |
|
||
|
Companies Covered in the report: |
|
||
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: Troponin Market by Product Type
4.1 Troponin Market Snapshot and Growth Engine
4.2 Troponin Market Overview
4.3 Troponin I
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 Key Market Trends, Growth Factors and Opportunities
4.3.4 Troponin I: Geographic Segmentation Analysis
4.4 Troponin T
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.4.3 Key Market Trends, Growth Factors and Opportunities
4.4.4 Troponin T: Geographic Segmentation Analysis
4.5 Troponin Complex
4.5.1 Introduction and Market Overview
4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.5.3 Key Market Trends, Growth Factors and Opportunities
4.5.4 Troponin Complex: Geographic Segmentation Analysis
4.6 and Others)
4.6.1 Introduction and Market Overview
4.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.6.3 Key Market Trends, Growth Factors and Opportunities
4.6.4 and Others): Geographic Segmentation Analysis
4.7
4.7.1 Introduction and Market Overview
4.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.7.3 Key Market Trends, Growth Factors and Opportunities
4.7.4 : Geographic Segmentation Analysis
Chapter 5: Troponin Market by Application
5.1 Troponin Market Snapshot and Growth Engine
5.2 Troponin Market Overview
5.3 Myocardial Infarction
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Myocardial Infarction: Geographic Segmentation Analysis
5.4 Acute Coronary Syndrome
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Acute Coronary Syndrome: Geographic Segmentation Analysis
5.5 Congestive Heart Failure
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Congestive Heart Failure: Geographic Segmentation Analysis
5.6 Cardiomyopathy
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.6.3 Key Market Trends, Growth Factors and Opportunities
5.6.4 Cardiomyopathy: Geographic Segmentation Analysis
5.7 and Others)
5.7.1 Introduction and Market Overview
5.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.7.3 Key Market Trends, Growth Factors and Opportunities
5.7.4 and Others): Geographic Segmentation Analysis
5.8
5.8.1 Introduction and Market Overview
5.8.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.8.3 Key Market Trends, Growth Factors and Opportunities
5.8.4 : Geographic Segmentation Analysis
Chapter 6: Troponin Market by End User
6.1 Troponin Market Snapshot and Growth Engine
6.2 Troponin Market Overview
6.3 Hospitals
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Hospitals: Geographic Segmentation Analysis
6.4 Diagnostics Laboratories
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Diagnostics Laboratories: Geographic Segmentation Analysis
6.5 Home Care Settings
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Home Care Settings: Geographic Segmentation Analysis
6.6 and Others)
6.6.1 Introduction and Market Overview
6.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.6.3 Key Market Trends, Growth Factors and Opportunities
6.6.4 and Others) : Geographic Segmentation Analysis
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Benchmarking
7.1.2 Troponin Market Share by Manufacturer (2023)
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Mergers and Acquisitions
7.2 ROCHE DIAGNOSTICS (SWITZERLAND)
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Role of the Company in the Market
7.2.5 Sustainability and Social Responsibility
7.2.6 Operating Business Segments
7.2.7 Product Portfolio
7.2.8 Business Performance
7.2.9 Key Strategic Moves and Recent Developments
7.2.10 SWOT Analysis
7.3 ABBOTT LABORATORIES (USA)
7.4 BECKMAN COULTER (USA)
7.5 RESPONSE BIOMEDICAL (CANADA)
7.6 VITRO (SPAIN)
7.7 SIEMENS HEALTHCARE GMBH (GERMANY)
7.8 RADIOMETER MEDICAL APS (DENMARK)
7.9 BIOMÉRIEUX SA (FRANCE)
7.10 THERMO FISHER SCIENTIFIC (USA)
7.11 MITSUBISHI CHEMICAL EUROPE (GERMANY)
7.12 AND OTHER PROMINENT PLAYERS
7.13 OTHER ACTIVE PLAYERS
Chapter 8: Global Troponin Market By Region
8.1 Overview
8.2. North America Troponin Market
8.2.1 Key Market Trends, Growth Factors and Opportunities
8.2.2 Top Key Companies
8.2.3 Historic and Forecasted Market Size by Segments
8.2.4 Historic and Forecasted Market Size By Product Type
8.2.4.1 Troponin I
8.2.4.2 Troponin T
8.2.4.3 Troponin Complex
8.2.4.4 and Others)
8.2.4.5
8.2.5 Historic and Forecasted Market Size By Application
8.2.5.1 Myocardial Infarction
8.2.5.2 Acute Coronary Syndrome
8.2.5.3 Congestive Heart Failure
8.2.5.4 Cardiomyopathy
8.2.5.5 and Others)
8.2.5.6
8.2.6 Historic and Forecasted Market Size By End User
8.2.6.1 Hospitals
8.2.6.2 Diagnostics Laboratories
8.2.6.3 Home Care Settings
8.2.6.4 and Others)
8.2.7 Historic and Forecast Market Size by Country
8.2.7.1 US
8.2.7.2 Canada
8.2.7.3 Mexico
8.3. Eastern Europe Troponin Market
8.3.1 Key Market Trends, Growth Factors and Opportunities
8.3.2 Top Key Companies
8.3.3 Historic and Forecasted Market Size by Segments
8.3.4 Historic and Forecasted Market Size By Product Type
8.3.4.1 Troponin I
8.3.4.2 Troponin T
8.3.4.3 Troponin Complex
8.3.4.4 and Others)
8.3.4.5
8.3.5 Historic and Forecasted Market Size By Application
8.3.5.1 Myocardial Infarction
8.3.5.2 Acute Coronary Syndrome
8.3.5.3 Congestive Heart Failure
8.3.5.4 Cardiomyopathy
8.3.5.5 and Others)
8.3.5.6
8.3.6 Historic and Forecasted Market Size By End User
8.3.6.1 Hospitals
8.3.6.2 Diagnostics Laboratories
8.3.6.3 Home Care Settings
8.3.6.4 and Others)
8.3.7 Historic and Forecast Market Size by Country
8.3.7.1 Russia
8.3.7.2 Bulgaria
8.3.7.3 The Czech Republic
8.3.7.4 Hungary
8.3.7.5 Poland
8.3.7.6 Romania
8.3.7.7 Rest of Eastern Europe
8.4. Western Europe Troponin Market
8.4.1 Key Market Trends, Growth Factors and Opportunities
8.4.2 Top Key Companies
8.4.3 Historic and Forecasted Market Size by Segments
8.4.4 Historic and Forecasted Market Size By Product Type
8.4.4.1 Troponin I
8.4.4.2 Troponin T
8.4.4.3 Troponin Complex
8.4.4.4 and Others)
8.4.4.5
8.4.5 Historic and Forecasted Market Size By Application
8.4.5.1 Myocardial Infarction
8.4.5.2 Acute Coronary Syndrome
8.4.5.3 Congestive Heart Failure
8.4.5.4 Cardiomyopathy
8.4.5.5 and Others)
8.4.5.6
8.4.6 Historic and Forecasted Market Size By End User
8.4.6.1 Hospitals
8.4.6.2 Diagnostics Laboratories
8.4.6.3 Home Care Settings
8.4.6.4 and Others)
8.4.7 Historic and Forecast Market Size by Country
8.4.7.1 Germany
8.4.7.2 UK
8.4.7.3 France
8.4.7.4 The Netherlands
8.4.7.5 Italy
8.4.7.6 Spain
8.4.7.7 Rest of Western Europe
8.5. Asia Pacific Troponin Market
8.5.1 Key Market Trends, Growth Factors and Opportunities
8.5.2 Top Key Companies
8.5.3 Historic and Forecasted Market Size by Segments
8.5.4 Historic and Forecasted Market Size By Product Type
8.5.4.1 Troponin I
8.5.4.2 Troponin T
8.5.4.3 Troponin Complex
8.5.4.4 and Others)
8.5.4.5
8.5.5 Historic and Forecasted Market Size By Application
8.5.5.1 Myocardial Infarction
8.5.5.2 Acute Coronary Syndrome
8.5.5.3 Congestive Heart Failure
8.5.5.4 Cardiomyopathy
8.5.5.5 and Others)
8.5.5.6
8.5.6 Historic and Forecasted Market Size By End User
8.5.6.1 Hospitals
8.5.6.2 Diagnostics Laboratories
8.5.6.3 Home Care Settings
8.5.6.4 and Others)
8.5.7 Historic and Forecast Market Size by Country
8.5.7.1 China
8.5.7.2 India
8.5.7.3 Japan
8.5.7.4 South Korea
8.5.7.5 Malaysia
8.5.7.6 Thailand
8.5.7.7 Vietnam
8.5.7.8 The Philippines
8.5.7.9 Australia
8.5.7.10 New Zealand
8.5.7.11 Rest of APAC
8.6. Middle East & Africa Troponin Market
8.6.1 Key Market Trends, Growth Factors and Opportunities
8.6.2 Top Key Companies
8.6.3 Historic and Forecasted Market Size by Segments
8.6.4 Historic and Forecasted Market Size By Product Type
8.6.4.1 Troponin I
8.6.4.2 Troponin T
8.6.4.3 Troponin Complex
8.6.4.4 and Others)
8.6.4.5
8.6.5 Historic and Forecasted Market Size By Application
8.6.5.1 Myocardial Infarction
8.6.5.2 Acute Coronary Syndrome
8.6.5.3 Congestive Heart Failure
8.6.5.4 Cardiomyopathy
8.6.5.5 and Others)
8.6.5.6
8.6.6 Historic and Forecasted Market Size By End User
8.6.6.1 Hospitals
8.6.6.2 Diagnostics Laboratories
8.6.6.3 Home Care Settings
8.6.6.4 and Others)
8.6.7 Historic and Forecast Market Size by Country
8.6.7.1 Turkiye
8.6.7.2 Bahrain
8.6.7.3 Kuwait
8.6.7.4 Saudi Arabia
8.6.7.5 Qatar
8.6.7.6 UAE
8.6.7.7 Israel
8.6.7.8 South Africa
8.7. South America Troponin Market
8.7.1 Key Market Trends, Growth Factors and Opportunities
8.7.2 Top Key Companies
8.7.3 Historic and Forecasted Market Size by Segments
8.7.4 Historic and Forecasted Market Size By Product Type
8.7.4.1 Troponin I
8.7.4.2 Troponin T
8.7.4.3 Troponin Complex
8.7.4.4 and Others)
8.7.4.5
8.7.5 Historic and Forecasted Market Size By Application
8.7.5.1 Myocardial Infarction
8.7.5.2 Acute Coronary Syndrome
8.7.5.3 Congestive Heart Failure
8.7.5.4 Cardiomyopathy
8.7.5.5 and Others)
8.7.5.6
8.7.6 Historic and Forecasted Market Size By End User
8.7.6.1 Hospitals
8.7.6.2 Diagnostics Laboratories
8.7.6.3 Home Care Settings
8.7.6.4 and Others)
8.7.7 Historic and Forecast Market Size by Country
8.7.7.1 Brazil
8.7.7.2 Argentina
8.7.7.3 Rest of SA
Chapter 9 Analyst Viewpoint and Conclusion
9.1 Recommendations and Concluding Analysis
9.2 Potential Market Strategies
Chapter 10 Research Methodology
10.1 Research Process
10.2 Primary Research
10.3 Secondary Research
|
Troponin Market |
|||
|
Base Year: |
2023 |
Forecast Period: |
2024-2032 |
|
Historical Data: |
2017 to 2023 |
Market Size in 2023: |
USD 1.39 Billion |
|
Forecast Period 2024-32 CAGR: |
12.6% |
Market Size in 2032: |
USD 4.04 Billion |
|
Segments Covered: |
By Product Type |
|
|
|
By Application |
|
||
|
By End User |
|
||
|
By Region |
|
||
|
Key Market Drivers: |
|
||
|
Key Market Restraints: |
|
||
|
Key Opportunities: |
|
||
|
Companies Covered in the report: |
|
||
